Dr. Michael Altorfer, CEO, Swiss Biotech Association
«Swiss Biotech Success Stories»

The recognition was awarded to:

  • Biogen for the many Swiss ingredients in its success story
  • Glycart (now Roche Glycart) for its role as pioneer in antibody engineering in cancer immunotherapy.
  • Okairos for its innovative T-cell based vaccines for major infectious diseases
  • Selexis for its advanced technologies in protein expression
  • Vifor Fresenius Medical Care Renal Pharma, a transformational joint venture

About the Swiss BioTech Success Stories

Swiss Biotech Success Stories illustrate the many accomplishments and honor those who have made important and sustainable contributions to the biotech industry in Switzerland. The recognition is awarded annually at the Swiss Biotech Day and reflects the diversity and variety of this industry sector.